Navigation Links
You may Be Risking Fatal Blood Clots Even While Reading This

You don’t have to fly long miles by economy class, to risk deep vein thrombosis, say experts. Their research has brought out a startling high risk// of the ‘economy class syndrome’ in those on terra firma, right here among us, in IT offices, call centers etc.

The research led by Professor Richard Beasley of New Zealand's privately funded Medical Research Institute says that office workers, who stay glued to computer screens, are at greater risk of deadly blood clots forming in their legs, than long-distance air travelers.

Deep-vein thrombosis, or DVT, is a condition in which a blood clot forms in the deep veins of the legs. The condition can be fatal if part of the clot breaks off and blocks a blood vessel in the lungs.

The condition has been linked to long-haul flights and dubbed "economy class syndrome," because passengers traveling coach often do not have the space or opportunity to stretch enough to reduce the risk of blood clotting.

The study, which covered 62 patients aged under 65 who were admitted to hospital with blood clots, found that 34 per cent of patients admitted to hospital with blood clots had been seated at work for long periods.

The 34 percent finding is far higher than the 1.4 percent of blood-clot patients who recently traveled on long-haul flights, and the study has shown a clear link between travel and work-related thrombosis.

Beasley lists surprise findings of the study as those that reflect the very sedentary nature of today’s working world- 12 to 14 hour daily shifts undertaken, almost constantly at the desk.

“Some of them (office workers) were going three to four hours at a time without getting up," he says.

The study will be published next month in the New Zealand Medical Journal.

'"/>




Page: 1

Related medicine news :

1. Blood Clots Could Be Very Fatal
2. Blood Transfusion A Likely Cause For A Rare And Fatal Brain Disorder
3. Understanding The Link Between Phobias And Fatal Heart Disease
4. Lip Piercing Can Be Fatal
5. Pakistan On Alert After Cases Of Fatal Fever
6. Drug Used To Arrest Bleeding Disorder Linked To Fatal Side Effects
7. Students Die after a Fatal Crash
8. Fatal Case of Meningitis Detected In Massachusetts
9. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
10. Figment of Imagination? A Powerful US Economy Gives Rise to Fatal Heart Attacks
11. Cyclone Glenda brings Threat of Fatal Mosquito–borne Diseas
Post Your Comments:
Breaking Medicine Technology:Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Haemonetics Sets Date for First Quarter Fiscal Year 2010 Earnings Release 3A August 3 2009 51439 1Varian Medical Systems Management to Present at the Piper Jaffray Cancer Summit 51436 1Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 1Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 2Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 3